1[1]F. Sohrabji, R. Miranda and C.D. Toran - Allerand, Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 1995 (92):11,110- 11,114.
2[2]L. Gollalpudi and M. M. Oblinger, Estrogen and NGF synergistically protect terminally differentiated, ER- transfected PC- 12cells from apoptosis. J. Neurosci. Res1999(56): 471 - 481.
3[3]B. Moosman and C. Behl, The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci. USA 1999(96): 8867 -8872.
4[4]Pattie S. Green and James W. Simpkins Neuroprotective effects of estrogens: potential mechanisms of action International Joumal of Developmental Neuroscience 2000 (18): 347 - 358.
5[5]L.M. Garcia - Scgura, P. Cardona - Gomez, F. Naftolin and J.A. Chowen, Estradiol upregulates bcl - 2 expression in adult brainneurons. Neuroreport 1998 (9): 595 - 597.
6[6]C.A. Singer, K.L. Rogers and D. M. Dorsa, Modulation of bcl 2 expression: a potential component of estrogen protection in NT2neurons. NeuroReport 1998(9) :2565 - 2568.
8[8]D.B. Dubal, P.J. Shughrue, M.E. Wilson, 1. Merchenthaler and P.M. Wise, Estradiol modulates bcl- 2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 1999( 19):6385-- 6393.
9[9]P.E. Stevis, D.C. Deecher, L. Suhadolnik and D. E. Frail,Fstradiol - BSA conjugates and their use in characterizing estrogen receptors. Endocrinology1999 (140): 5455 - 5458.
10[10]J. Bishop and J.W. Simpkins, Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol. Cell Neurosci. 1994(5): 303 - 308.
